Publication:
Evaluation of vaccination strategies for the metropolitan area of Madrid via agent-based simulation

dc.contributor.authorSingh, David E
dc.contributor.authorOlmedo-Lucerón, Carmen
dc.contributor.authorLimia Sánchez, Aurora
dc.contributor.authorGuzman Merino, Miguel
dc.contributor.authorDuran Gonzalez, Christian
dc.contributor.authorDelgado-Sanz, Concepcion
dc.contributor.authorGomez-Barroso, Diana
dc.contributor.authorCarretero, Jesus
dc.contributor.authorMarinescu, Maria-Cristina
dc.contributor.funderComunidad de Madrid (España)
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
dc.contributor.funderCarlos III University of Madrid (España)
dc.date.accessioned2023-04-17T09:44:05Z
dc.date.available2023-04-17T09:44:05Z
dc.date.issued2022-12-09
dc.description.abstractObjective: We analyse the impact of different vaccination strategies on the propagation of COVID-19 within the Madrid metropolitan area, starting on 27 December 2020 and ending in Summer of 2021. Materials and methods: The predictions are based on simulation using EpiGraph, an agent-based COVID-19 simulator. We first summarise the different models implemented in the simulator, then provide a comprehensive description of the vaccination model and define different vaccination strategies. The simulator-including the vaccination model-is validated by comparing its results with real data from the metropolitan area of Madrid during the third COVID-19 wave. This work considers different COVID-19 propagation scenarios for a simulated population of about 5 million. Results: The main result shows that the best strategy is to vaccinate first the elderly with the two doses spaced 56 days apart; this approach reduces the final infection rate by an additional 6% and the number of deaths by an additional 3% with respect to vaccinating first the elderly at the interval recommended by the vaccine producer. The reason is the increase in the number of vaccinated individuals at any time during the simulation. Conclusion: The existing level of detail and maturity of EpiGraph allowed us to evaluate complex scenarios and thus use it successfully to help guide the strategy for the COVID-19 vaccination campaign of the Spanish health authorities.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThis work has been partially funded by the agreement between the Community of Madrid and the Carlos III University of Madrid for the funding of research projects on SARS-CoV-2 and COVID-19 disease, project name 'Multi-source and multi-method prediction to support COVID-19 policy decision making', which was supported with REACT-EU funds from the European regional development fund 'a way of making Europe' (2020/00692/003) and the European High-Performance Computing Joint Undertaking (JU) under the ADMIRE project (grant agreement No 956748). We have also used the Spanish Supercomputing Network (RES) under the grant BCV-2021-1-0011. The role of all study sponsors was limited to financial support.es_ES
dc.format.number12es_ES
dc.format.pagee065937es_ES
dc.format.volume12es_ES
dc.identifier.citationBMJ Open. 2022 Dec 9;12(12):e065937.es_ES
dc.identifier.doi10.1136/bmjopen-2022-065937es_ES
dc.identifier.e-issn2044-6055es_ES
dc.identifier.journalBMJ openes_ES
dc.identifier.pubmedID36600331es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/15822
dc.language.isoenges_ES
dc.publisherBMJ Publishing Group
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/2020/00692/003es_ES
dc.relation.publisherversionhttps://doi.org/10.1136/bmjopen-2022-065937es_ES
dc.repisalud.centroISCIII::Centro Nacional de Epidemiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución-NoComercial 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.subjectCOVID-19es_ES
dc.subjectEpidemiologyes_ES
dc.subjectHealth policyes_ES
dc.subjectPublic healthes_ES
dc.subjectHealth Services Administration & Managementes_ES
dc.subject.meshCOVID-19es_ES
dc.subject.meshVaccineses_ES
dc.subject.meshHumanses_ES
dc.subject.meshAgedes_ES
dc.subject.meshCOVID-19 Vaccineses_ES
dc.subject.meshVaccinationes_ES
dc.subject.meshComputer Simulationes_ES
dc.titleEvaluation of vaccination strategies for the metropolitan area of Madrid via agent-based simulationes_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicatione89a616b-8c7b-43b9-b3df-2a44c45e0765
relation.isAuthorOfPublicationdffea7c1-0d44-4b8a-aa55-53669a24a097
relation.isAuthorOfPublication.latestForDiscoverye89a616b-8c7b-43b9-b3df-2a44c45e0765
relation.isFunderOfPublicationc87c70a3-e023-4b6b-ac25-1b2d1b483786
relation.isFunderOfPublicationefa64f05-b985-4984-8f1e-5fc4ef21f502
relation.isFunderOfPublication2f7895b1-77c2-4191-a46f-42b5e9b9f083
relation.isFunderOfPublication.latestForDiscoveryc87c70a3-e023-4b6b-ac25-1b2d1b483786
relation.isPublisherOfPublication7ffe3d60-d8d6-4023-8234-aa60d8420845
relation.isPublisherOfPublication.latestForDiscovery7ffe3d60-d8d6-4023-8234-aa60d8420845

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
EvaluationVaccinationStrategiesMetropolitan_2022.pdf
Size:
1021.43 KB
Format:
Adobe Portable Document Format
Description: